ABBOTINDIA

Company Overview

Key Business Segments: Pharmaceuticals: Abbott India offers a wide range of branded generic medicines, with a strong presence in women's health, gastroenterology, cardiology, metabolic disorders, and central nervous system. Nutrition: The company provides nutritional products for infants, children, adults, and people with specific dietary needs. Diagnostics & Medical Devices: Abbott is also involved in the diagnostics market and offers medical devices such as blood glucose meters, vascular devices, and other health monitoring technologies. Financial and Fundamental Analysis Key Financial Highlights (as of March 2025): Market Capitalization: Approximately ₹69,336 Crores. Debt-to-Equity Ratio: The company is virtually debt-free, with a debt-to-equity ratio of 0.0, which is a strong indicator of financial stability. Promoter Holding: Promoters maintain a high holding of 74.99%, demonstrating strong conviction in the company's future. Profitability: The company has maintained healthy profit margins and has shown consistent profit growth over the past few years. Valuation: The stock is currently trading at a high Price-to-Earnings (P/E) ratio of approximately 47.7, which is a key consideration for valuation analysis. Recent Performance and Trends: Revenue and Profit Growth: Abbott India has shown consistent growth in both revenue and profit after tax (PAT) over the last five years. Operational Efficiency: The company has an efficient cash conversion cycle and maintains a healthy liquidity position. Return Ratios: It has demonstrated healthy return on equity (ROE) and return on capital employed (ROCE), which reflect its efficient use of capital.